GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (TSXV:HEM) » Definitions » Cyclically Adjusted FCF per Share

Hemostemix (TSXV:HEM) Cyclically Adjusted FCF per Share : C$-0.63 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Hemostemix Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hemostemix's adjusted free cash flow per share for the three months ended in Dec. 2023 was C$-0.002. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$-0.63 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-05-17), Hemostemix's current stock price is C$0.04. Hemostemix's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was C$-0.63. Hemostemix's Cyclically Adjusted Price-to-FCF of today is .


Hemostemix Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Hemostemix's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemostemix Cyclically Adjusted FCF per Share Chart

Hemostemix Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.83 -0.63

Hemostemix Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.83 -0.82 -0.72 -0.61 -0.63

Competitive Comparison of Hemostemix's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Hemostemix's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemostemix's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemostemix's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hemostemix's Cyclically Adjusted Price-to-FCF falls into.



Hemostemix Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hemostemix's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.002/125.0724*125.0724
=-0.002

Current CPI (Dec. 2023) = 125.0724.

Hemostemix Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201402 -0.389 98.051 -0.496
201405 -0.204 99.394 -0.257
201408 -1.241 99.315 -1.563
201412 -0.259 98.367 -0.329
201503 -0.223 99.789 -0.280
201506 -0.247 100.500 -0.307
201509 -0.304 100.421 -0.379
201512 -0.241 99.947 -0.302
201603 -0.186 101.054 -0.230
201606 -0.050 102.002 -0.061
201609 -0.418 101.765 -0.514
201612 -0.127 101.449 -0.157
201703 -0.168 102.634 -0.205
201706 -0.082 103.029 -0.100
201709 -0.131 103.345 -0.159
201712 -0.105 103.345 -0.127
201803 0.066 105.004 0.079
201806 -0.075 105.557 -0.089
201809 -0.095 105.636 -0.112
201812 -0.076 105.399 -0.090
201903 -0.056 106.979 -0.065
201906 -0.073 107.690 -0.085
201909 -0.086 107.611 -0.100
201912 -0.012 107.769 -0.014
202003 -0.010 107.927 -0.012
202006 -0.033 108.401 -0.038
202009 -0.014 108.164 -0.016
202012 -0.103 108.559 -0.119
202103 0.018 110.298 0.020
202106 -0.029 111.720 -0.032
202109 -0.015 112.905 -0.017
202112 -0.033 113.774 -0.036
202203 -0.007 117.646 -0.007
202206 -0.053 120.806 -0.055
202209 -0.015 120.648 -0.016
202212 -0.010 120.964 -0.010
202303 -0.009 122.702 -0.009
202306 -0.005 124.203 -0.005
202309 -0.001 125.230 -0.001
202312 -0.002 125.072 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Hemostemix  (TSXV:HEM) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Hemostemix Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Hemostemix's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemostemix (TSXV:HEM) Business Description

Industry
Traded in Other Exchanges
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Executives
Thomas Smeenk Director

Hemostemix (TSXV:HEM) Headlines

No Headlines